ID ACSM2_RAT Reviewed; 572 AA. AC O70490; Q6AZ63; DT 02-OCT-2007, integrated into UniProtKB/Swiss-Prot. DT 02-OCT-2007, sequence version 2. DT 24-JAN-2024, entry version 123. DE RecName: Full=Acyl-coenzyme A synthetase ACSM2, mitochondrial; DE EC=6.2.1.2 {ECO:0000250|UniProtKB:Q68CK6}; DE AltName: Full=Acyl-CoA synthetase medium-chain family member 2; DE AltName: Full=Benzoate--CoA ligase; DE EC=6.2.1.25 {ECO:0000250|UniProtKB:Q68CK6}; DE AltName: Full=Butyrate--CoA ligase 2; DE AltName: Full=Butyryl-coenzyme A synthetase 2; DE AltName: Full=Kidney-specific protein KS; DE AltName: Full=Middle-chain acyl-CoA synthetase 2; DE Flags: Precursor; GN Name=Acsm2; Synonyms=Ks; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, INDUCTION, AND TISSUE RP SPECIFICITY. RC STRAIN=Sprague-Dawley; TISSUE=Kidney; RX PubMed=9844120; DOI=10.1046/j.1523-1755.1998.00143.x; RA Hilgers K.F., Nagaraj S.K., Karginova E.A., Kazakova I.G., Chevalier R.L., RA Carey R.M., Pentz E.S., Gomez R.A.; RT "Molecular cloning of KS, a novel rat gene expressed exclusively in the RT kidney."; RL Kidney Int. 54:1444-1454(1998). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Catalyzes the activation of fatty acids by CoA to produce an CC acyl-CoA, the first step in fatty acid metabolism (By similarity). CC Capable of activating medium-chain fatty acids (e.g. butyric (C4) to CC decanoic (C10) acids), and certain carboxylate-containing xenobiotics, CC e.g. benzoate (By similarity). {ECO:0000250|UniProtKB:Q68CK6}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a medium chain fatty acid + ATP + CoA = a medium-chain fatty CC acyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:48340, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, CC ChEBI:CHEBI:59558, ChEBI:CHEBI:90546, ChEBI:CHEBI:456215; EC=6.2.1.2; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48341; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + benzoate + CoA = AMP + benzoyl-CoA + diphosphate; CC Xref=Rhea:RHEA:10132, ChEBI:CHEBI:16150, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57369, CC ChEBI:CHEBI:456215; EC=6.2.1.25; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10133; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + hexanoate = AMP + diphosphate + hexanoyl-CoA; CC Xref=Rhea:RHEA:43740, ChEBI:CHEBI:17120, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:62620, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43741; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + butanoate + CoA = AMP + butanoyl-CoA + diphosphate; CC Xref=Rhea:RHEA:46172, ChEBI:CHEBI:17968, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57371, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46173; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + octanoate = AMP + diphosphate + octanoyl-CoA; CC Xref=Rhea:RHEA:33631, ChEBI:CHEBI:25646, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57386, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33632; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + CoA + decanoate = AMP + decanoyl-CoA + diphosphate; CC Xref=Rhea:RHEA:33627, ChEBI:CHEBI:27689, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:61430, CC ChEBI:CHEBI:456215; Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33628; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000250|UniProtKB:Q68CK6}; CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q68CK6}. CC -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q68CK6}. CC -!- TISSUE SPECIFICITY: Detected in kidney, in proximal tubules. CC {ECO:0000269|PubMed:9844120}. CC -!- DEVELOPMENTAL STAGE: First detected in kidney from 1 week old rats. Not CC detectable in fetal kidney and in kidney from newborn rats. CC {ECO:0000269|PubMed:9844120}. CC -!- INDUCTION: Down-regulated in kidneys from a strain of spontaneously CC hypertensive rats (SHR). Down-regulated after unilateral ureteral CC obstruction or unilateral nephrectomy. {ECO:0000269|PubMed:9844120}. CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF062389; AAD05209.1; -; mRNA. DR EMBL; BC078721; AAH78721.1; -; mRNA. DR RefSeq; NP_653349.1; NM_144748.1. DR AlphaFoldDB; O70490; -. DR SMR; O70490; -. DR iPTMnet; O70490; -. DR PhosphoSitePlus; O70490; -. DR PaxDb; 10116-ENSRNOP00000020587; -. DR GeneID; 246263; -. DR KEGG; rno:246263; -. DR UCSC; RGD:708383; rat. DR AGR; RGD:708383; -. DR CTD; 233799; -. DR RGD; 708383; Acsm2. DR eggNOG; KOG1175; Eukaryota. DR InParanoid; O70490; -. DR OrthoDB; 5474118at2759; -. DR PhylomeDB; O70490; -. DR TreeFam; TF354287; -. DR Reactome; R-RNO-177128; Conjugation of salicylate with glycine. DR Reactome; R-RNO-177135; Conjugation of benzoate with glycine. DR Reactome; R-RNO-177162; Conjugation of phenylacetate with glutamine. DR Reactome; R-RNO-9749641; Aspirin ADME. DR PRO; PR:O70490; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0005759; C:mitochondrial matrix; IBA:GO_Central. DR GO; GO:0005739; C:mitochondrion; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0018858; F:benzoate-CoA ligase activity; ISS:UniProtKB. DR GO; GO:0047760; F:butyrate-CoA ligase activity; ISO:RGD. DR GO; GO:0102391; F:decanoate-CoA ligase activity; IEA:RHEA. DR GO; GO:0015645; F:fatty acid ligase activity; IBA:GO_Central. DR GO; GO:0004321; F:fatty-acyl-CoA synthase activity; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0006637; P:acyl-CoA metabolic process; IBA:GO_Central. DR GO; GO:0006633; P:fatty acid biosynthetic process; IBA:GO_Central. DR GO; GO:0036112; P:medium-chain fatty-acyl-CoA metabolic process; ISO:RGD. DR Gene3D; 3.30.300.30; -; 1. DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1. DR InterPro; IPR025110; AMP-bd_C. DR InterPro; IPR045851; AMP-bd_C_sf. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_Synth/Lig_com. DR InterPro; IPR042099; ANL_N_sf. DR PANTHER; PTHR43605; ACYL-COENZYME A SYNTHETASE; 1. DR PANTHER; PTHR43605:SF3; ACYL-COENZYME A SYNTHETASE ACSM2B, MITOCHONDRIAL; 1. DR Pfam; PF00501; AMP-binding; 1. DR Pfam; PF13193; AMP-binding_C; 1. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 1. DR PROSITE; PS00455; AMP_BINDING; 1. PE 2: Evidence at transcript level; KW ATP-binding; Fatty acid metabolism; Ligase; Lipid metabolism; Magnesium; KW Metal-binding; Mitochondrion; Nucleotide-binding; Reference proteome; KW Transit peptide. FT TRANSIT 1..46 FT /note="Mitochondrion" FT /evidence="ECO:0000255" FT CHAIN 47..572 FT /note="Acyl-coenzyme A synthetase ACSM2, mitochondrial" FT /id="PRO_0000306096" FT BINDING 139 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 221..229 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 359..364 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 364 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 446 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 461 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 469..471 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 472 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 501 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 532 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 540..542 FT /ligand="CoA" FT /ligand_id="ChEBI:CHEBI:57287" FT /evidence="ECO:0000250" FT BINDING 557 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT CONFLICT 22 FT /note="T -> S (in Ref. 1; AAD05209)" FT /evidence="ECO:0000305" FT CONFLICT 99 FT /note="G -> R (in Ref. 2; AAH78721)" FT /evidence="ECO:0000305" SQ SEQUENCE 572 AA; 64145 MW; 34BB5FB87A43958C CRC64; MHWLWKIPRL CTFWGTEMFH RTFHMNIKKL MPIQWGHQEV PAKFNFASDV IDHWASLEKA GKRSPGPALW WMNGSGEELK WNFRELSEIS KQTANVLTGA CGLQRGDRVA VVLPRVPEWW LVTLGCMRSG LVFMPGTTQM KSTDILYRLQ SSKARAIVAG DEVVQEVDAV APDCSFLKIK LLVSEKNREG WLNFKALLKD ASPIHQCVET VSQESAAIYF TSGTSGPPKM AEHSHCSLGL KAKMDAGWTG LGPSDTMWTI SDTGWILNIL GSFLEPWVLG TCIFVHLLPK FDPQTVLKVL SSYPINTLLG APLIYRMLLQ QDLSSYKFPH LHSCFSGGET LLPETLESWK AKTGLEIREI YGQTETGITC RVSRTMKVKP GYLGTAIVPY DVQVIDEQGN VLPPGKEGDM ALRVKPIRPI GMFSGYVDNP KKTQANIRGD FWLLGDRGIK DTEGYFHFMG RTDDIINSSG YRIGPSEVEN ALMEHPAVVE TAVISSPDPI RREVVKAFVV LAPEFLSHDQ DQLTKVLQEH VKSVTAPYKY PRKVEFVLDL PKTITGKIER AKLRAKEWKT SG //